The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
aprepitant · Injection, Emulsion
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 40 mg · Capsule · #1 blister pack/carton / 1 capsule in 1 blister pack · 80 mg · Capsule · #2 capsules/dose pack · 40 mg · Capsule · #5 blister packs/carton / 1 capsule in 1 blister pack · Kit · #1 kit/dose pack * 2 capsule in 1 blister pack * 1 capsule in 1 blister pack
What changed in the last 90 days
Every detected change for aprepitant, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- AprepitantAug 19, 2026Price downNADAC $117.60714 → $115.11438 per unit (-2.12%)
- AprepitantAug 19, 2026Price upNADAC $71.05296 → $76.85193 per unit (+8.16%)
- AprepitantAug 19, 2026Price upNADAC $71.05296 → $76.85193 per unit (+8.16%)
- AprepitantAug 19, 2026Price upNADAC $41.96595 → $45.38809 per unit (+8.15%)
- AprepitantAug 19, 2026Price upNADAC $41.96595 → $45.38809 per unit (+8.15%)
- AprepitantAug 19, 2026Price downNADAC $91.73183 → $87.26617 per unit (-4.87%)
- AprepitantAug 19, 2026Price downNADAC $91.73183 → $87.26617 per unit (-4.87%)
- AprepitantAug 19, 2026Price downNADAC $117.60714 → $115.11438 per unit (-2.12%)
- AprepitantAug 19, 2026Price upNADAC $71.05296 → $76.85193 per unit (+8.16%)
- AprepitantAug 19, 2026Price upNADAC $71.05296 → $76.85193 per unit (+8.16%)
Same drug class
Other molecules FDA puts in Substance P/Neurokinin-1 Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Aprepitant in shortage right now?
- No. FDA does not currently list Aprepitant in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Aprepitant?
- 19 companies have marketed Aprepitant in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Aprepitant cost?
- The typical pharmacy pays about $76.85 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.